{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:53:32Z","timestamp":1789588412255,"version":"build-2803163510"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T00:00:00Z","timestamp":1679443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Some studies had reported that patients with viral hepatitis are at increased risk of reduced bone mineral density and even osteoporosis. However, the interaction between reduced bone mineral density (BMD) and viral hepatitis remains inconclusive. Therefore, our study collected hepatitis test results and bone mineral density from respondents in the NHANES database. The aim of this study was to investigate whether there is an association between hepatitis and a decrease in bone mineral density.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The respondents with both hepatitis- and BMD-related indicators from the NHANES database in the United States from 2005\u20132010, 2013\u20132014, to 2017\u20132020 were collected for this study. BMD were compared between respondents who were positive and negative for respondents related to hepatitis B and C. BMD was measured using dual-energy X-ray absorptiometry of the femur and lumbar spine. Finally, multiple regression analysis was performed between hepatitis B surface antigen (HBsAg) and hepatitis C RNA (HCV-RNA) and BMD in the respondents.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 15,642 respondents were included in the hepatitis B surface antigen-related survey. Of these, 1,217 respondents were positive for hepatitis B surface antigen. A total of 5111 hepatitis C RNA-related responders were included. Hepatitis C RNA-positive had 268 respondents. According to the results of the multiple regression analysis, the femoral BMD was significantly lower in HBsAg (+) respondents compared to HBsAg (\u2013) respondents: \u22120.018 (\u22120.026, \u22120.009) (<jats:italic>P<\/jats:italic> &amp;lt; 0.01). Moreover, spinal BMD was significantly lower in HBsAg (+) respondents compared to HBsAg (\u2013) respondents: \u22120.020 (\u22120.030, \u22120.010) (<jats:italic>P<\/jats:italic> &amp;lt; 0.01). According to the results of multiple regression analysis for hepatitis C RNA, HCV-RNA (+) respondents had significantly lower BMD compared to HCV-RNA (\u2013) respondents: \u22120.043 (\u22120.059, \u22120.026) (<jats:italic>P<\/jats:italic> &amp;lt; 0.01).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>During the analysis of respondents in the NHANES database in the United States, positive tests for hepatitis B surface antigen and hepatitis C RNA were found to be associated with a reduction in BMD. Positive serology for these hepatitis indicators may increase the risk of reduced BMD. Of course, this conclusion still needs to be further confirmed by more large clinical trials.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2023.1120083","type":"journal-article","created":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T04:41:00Z","timestamp":1679460060000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Seropositive for hepatitis B and C viruses is associated with the risk of decreased bone mineral density in adults: An analysis of studies from the NHANES database"],"prefix":"10.3389","volume":"10","author":[{"given":"Jiasheng","family":"Tao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijian","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenmian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.3390\/ijms22042105","article-title":"Osteoporosis in men: a review of an underestimated bone condition","volume":"22","author":"Rinonapoli","year":"2021","journal-title":"Int J Mol Sci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/joim.12873","article-title":"Treating osteoporosis to prevent fractures: current concepts and future developments","volume":"285","author":"Lorentzon","year":"2019","journal-title":"J Intern Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1210\/endrev\/bnab028","article-title":"Secondary osteoporosis","volume":"43","author":"Ebeling","year":"2022","journal-title":"Endocr Rev."},{"key":"B4","doi-asserted-by":"publisher","first-page":"4499","DOI":"10.3390\/nu13124499","article-title":"Exercise and nutrition impact on osteoporosis and sarcopenia-the incidence of osteosarcopenia: a narrative review","volume":"13","author":"Papadopoulou","year":"2021","journal-title":"Nutrients."},{"key":"B5","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S2213-8587(21)00020-6","article-title":"Chronic hepatitis, osteoporosis, and men: under-recognised and underdiagnosed","volume":"9","author":"Prasad","year":"2021","journal-title":"Lancet Diabetes Endocrinol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"4270","DOI":"10.3390\/ijms20174270","article-title":"Bone diseases in patients with chronic liver disease","volume":"20","author":"Jeong","year":"2019","journal-title":"Int J Mol Sci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1093\/cid\/cix1011","article-title":"The differential effects of human immunodeficiency virus and hepatitis C virus on bone microarchitecture and fracture risk","volume":"66","author":"Bedimo","year":"2018","journal-title":"Clin Infect Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1111\/cen.13762","article-title":"The association between liver cirrhosis and fracture risk: a systematic review and meta-analysis","volume":"89","author":"Liang","year":"2018","journal-title":"Clin Endocrinol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1007\/s00198-019-04870-6","article-title":"Bone microarchitecture and bone turnover in hepatic cirrhosis","volume":"30","author":"Wakolbinger","year":"2019","journal-title":"Osteoporos Int."},{"key":"B10","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s11657-019-0590-5","article-title":"The association between hepatitis and osteoporosis: a nested case-control study using a national sample cohort","volume":"14","author":"Min","year":"2019","journal-title":"Arch Osteoporos."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.3390\/ijms22052604","article-title":"An overview of the molecular mechanisms contributing to musculoskeletal disorders in chronic liver disease: osteoporosis, sarcopenia, and osteoporotic sarcopenia","volume":"22","author":"Yang","year":"2021","journal-title":"Int J Mol Sci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1002\/hep4.1234","article-title":"Suboptimal level of bone-forming cells in advanced cirrhosis are associated with hepatic osteodystrophy","volume":"2","author":"Bihari","year":"2018","journal-title":"Hepatol Commun."},{"key":"B13","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S2468-1253(19)30349-8","article-title":"The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"5","author":"GBD","year":"2020","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/S2468-1253(22)00050-4","article-title":"Worldwide prevalence of hepatitis B virus and hepatitis C virus among patients with cirrhosis at country, region, and global levels: a systematic review","volume":"7","author":"Alberts","year":"2022","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.coviro.2018.01.007","article-title":"Role of HBx in hepatitis B virus persistence and its therapeutic implications","volume":"30","author":"Slagle","year":"2018","journal-title":"Curr Opin Virol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.2105\/AJPH.2021.306517","article-title":"The national health and nutrition examination survey (NHANES), 2021\u20132022: adapting data collection in a COVID-19 environment","volume":"111","author":"Paulose-Ram","year":"2021","journal-title":"Am J Public Health."},{"key":"B17","unstructured":"Centers for Disease Control and Prevention NCHS Research Ethics Review Board (ERB) Approval"},{"key":"B18","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s00198-020-05756-8","article-title":"Osteoporosis case ascertainment strategies in European and Asian countries: a comparative review","volume":"32","author":"Burden","year":"2021","journal-title":"Osteoporos Int."},{"key":"B19","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1186\/s13018-021-02821-8","article-title":"Global prevalence of osteoporosis among the world older adults: a comprehensive systematic review and meta-analysis","volume":"16","author":"Nader","year":"2021","journal-title":"J Orthop Surg Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.3390\/jcm11092522","article-title":"Osteosarcopenia-the role of dual-energy X-ray absorptiometry (DXA) in diagnostics","volume":"11","author":"Gonera-Furman","year":"2022","journal-title":"J Clin Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.bone.2017.01.033","article-title":"Quality in dual-energy X-ray absorptiometry scans","volume":"104","author":"Morgan","year":"2017","journal-title":"Bone."},{"key":"B22","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/jmv.21146","article-title":"Improved detection of natural hepatitis B virus surface antigen (HBsAg) mutants by a new version of the VITROS HBsAg assay","volume":"80","author":"Echevarr\u00eda","year":"2008","journal-title":"J Med Virol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1128\/JCM.43.4.1669-1673.2005","article-title":"Dynamic range of hepatitis C virus RNA quantification with the Cobas Ampliprep-Cobas Amplicor HCV Monitor v20 assay","volume":"43","author":"Gourlain","year":"2005","journal-title":"J Clin Microbiol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.3390\/ijms20061358","article-title":"Molecular mechanisms driving progression of liver cirrhosis towards hepatocellular carcinoma in chronic hepatitis B and C infections: a review","volume":"20","author":"Kanda","year":"2019","journal-title":"Int J Mol Sci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.3389\/fimmu.2020.01760","article-title":"Editorial: advances in liver inflammation and fibrosis due to infectious diseases","volume":"11","author":"Oliveira","year":"2020","journal-title":"Front Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/cen.12780","article-title":"The risk of osteoporosis in patients with liver cirrhosis: a meta-analysis of literature studies","volume":"84","author":"Lupoli","year":"2016","journal-title":"Clin Endocrinol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"342","DOI":"10.4103\/sjg.SJG_74_18","article-title":"Bone mineral density loss in patients with cirrhosis","volume":"24","author":"Muhsen","year":"2018","journal-title":"Saudi J Gastroenterol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1097\/QAD.0000000000000952","article-title":"Mechanisms of bone disease in HIV and hepatitis C virus: impact of bone turnover, tenofovir exposure, sex steroids and severity of liver disease","volume":"30","author":"Bedimo","year":"2016","journal-title":"AIDS."},{"key":"B29","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1007\/s12072-021-10148-z","article-title":"A novel evidence of serial changes of bone mineral density in chronic hepatitis B patients treated with entecavir","volume":"15","author":"Huang","year":"2021","journal-title":"Hepatol Int."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.3748\/wjg.v27.i13.1267","article-title":"Metabolic complications of hepatitis C virus infection","volume":"27","author":"Chaudhari","year":"2021","journal-title":"World J Gastroenterol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1002\/hep.29420","article-title":"Sarcopenia in hiding: the risk and consequence of underestimating muscle dysfunction in nonalcoholic steatohepatitis","volume":"66","author":"Bhanji","year":"2017","journal-title":"Hepatology."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.3748\/wjg.v28.i22.2429","article-title":"Metabolic aspects of hepatitis C virus","volume":"28","author":"El-Kassas","year":"2022","journal-title":"World J Gastroenterol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"116431","DOI":"10.1016\/j.bone.2022.116431","article-title":"Trimethylamine N-oxide and hip fracture and bone mineral density in older adults: the cardiovascular health study","volume":"161","author":"Elam","year":"2022","journal-title":"Bone."},{"key":"B34","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13098-022-00840-x","article-title":"The relationship between central obesity and bone mineral density: a Mendelian randomization study","volume":"14","author":"Du","year":"2022","journal-title":"Diabetol Metab Syndr."},{"key":"B35","doi-asserted-by":"publisher","first-page":"dgab459","DOI":"10.1210\/clinem\/dgab459","article-title":"Protective role of DHEAS in age-related changes in bone mass and fracture risk","volume":"106","author":"Yokomoto-Umakoshi","year":"2021","journal-title":"J Clin Endocrinol Metab."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1097\/GME.0000000000001375","article-title":"Trabecular bone score of postmenopausal women is positively correlated with bone mineral density and negatively correlated with age and body mass index","volume":"26","author":"Torgutalp","year":"2019","journal-title":"Menopause."},{"key":"B37","doi-asserted-by":"publisher","first-page":"5069","DOI":"10.1038\/s41598-019-41674-4","article-title":"Crosssectional assessment of bone mass density in adults with hepatitis B virus and hepatitis C virus infection","volume":"9","author":"Chen","year":"2019","journal-title":"Sci Rep."},{"key":"B38","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1007\/s12072-015-9672-7","article-title":"Males seropositive for hepatitis B surface antigen are at risk of lower bone mineral density: the 2008\u20132010 Korea National Health and Nutrition Examination Surveys","volume":"10","author":"Baeg","year":"2016","journal-title":"Hepatol Int."},{"key":"B39","doi-asserted-by":"publisher","first-page":"216","DOI":"10.4103\/sjg.SJG_161_17","article-title":"Hepatitis C virus infection and risk of osteoporosis: a meta-analysis","volume":"23","author":"Wijarnpreecha","year":"2017","journal-title":"Saudi J Gastroenterol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s00223-012-9653-y","article-title":"Association between chronic hepatitis C virus infection and bone mineral density","volume":"91","author":"Lin","year":"2012","journal-title":"Calcif Tissue Int."},{"key":"B41","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1002\/jcsm.12269","article-title":"Association between pre-sarcopenia, sarcopenia, and bone mineral density in patients with chronic hepatitis C","volume":"9","author":"Bering","year":"2018","journal-title":"J Cachexia Sarcop Muscle."},{"key":"B42","doi-asserted-by":"publisher","first-page":"4844","DOI":"10.1210\/jc.2009-0835","article-title":"Bone mineral density and serum levels of soluble tumor necrosis factors, estradiol, and osteoprotegerin in postmenopausal women with cirrhosis after viral hepatitis","volume":"94","author":"Gonz\u00e1lez-Calvin","year":"2009","journal-title":"J Clin Endocrinol Metab."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1007\/s10620-014-3507-6","article-title":"Bone mineral density, bone turnover, and systemic inflammation in non-cirrhotics with chronic hepatitis C","volume":"60","author":"Lai","year":"2015","journal-title":"Dig Dis Sci."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1120083\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T04:41:05Z","timestamp":1679460065000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1120083\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,22]]},"references-count":43,"alternative-id":["10.3389\/fmed.2023.1120083"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2023.1120083","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,22]]},"article-number":"1120083"}}